Regulation
What’s UpDoc? The SaMD developer says it’s the first FDA-cleared clinical AI platform
UpDoc obtained FDA 510(k) clearance for a software-as-a-medical-device platform that integrates patient-facing large language models for clinical use, marking what the company claims is the first such FDA-cleared SaMD of its kind. The clearance signals regulatory acceptance of LLM-based clinical AI tools and may establish a pathway for similar developers.
The source
This brief is a MedIndexer summary of reporting by Medical Design & Outsourcing. To read the full story, head to the source.
Read the full story at Medical Design & Outsourcing